Evidence map›Paper›PMID 42223746›Full record

ReviewJournal of computer-aided molecular design2026

The (r)evolution of chemical space and molecular modeling: a time-resolved perspective.

Aylin Del Moral-Morales, Francisco L Feitosa, Carolina Horta Andrade, José L Medina-Franco

Abstract readReview
In one paragraph

Review in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aylin Del Moral-MoralesDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City, 04510, Mexico. adelmoral@cua.uam.mx.ORCID 0000-0003-3985-628X
Francisco L FeitosaDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City, 04510, Mexico.ORCID 0009-0006-0619-4514
Carolina Horta AndradeLaboratory for Molecular Modeling and Drug Design (LabMol), Faculty of Pharmacy, Universidade Federal de Goiás, Rua 240, 406, Goiânia, Goiás, 74605-220, Brazil.ORCID 0000-0003-0101-1492
José L Medina-FrancoDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City, 04510, Mexico. medinajl@unam.mx.ORCID 0000-0003-4940-1107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number and types of chemical compounds are expanding at an unprecedented rate. To model existing chemicals and aid in the design of novel chemical structures, appropriate computational approaches, tailored to the goals of specific projects, have evolved over time. This review analyzes the expansion of "chemical space" by tracing the historical milestones that have shaped molecular modeling from its inception to the present day. Utilizing data from public compound databases and a systematic bibliometric analysis of peer-reviewed literature, including specialized sources like the Journal of Computer-Aided Molecular Design, we mapped the co-evolution of chemical data and the algorithms designed to process it. While drug discovery has historically been the primary driver of this growth, our discussion extends to other domains, including macromolecular structural space. Due to the nature of public data, this analysis focuses mostly on open-access repositories with a few mentions of proprietary industrial libraries. By examining the trends in publications, this article provides a perspective on the current state of the field and the future trajectories of molecular modeling in an era of big data and artificial intelligence.

Indexed as

Drug DiscoveryModels, MolecularAlgorithmsArtificial IntelligenceComputer-Aided DesignDatabases, ChemicalDrug DesignSmall Molecule LibrariesSmall Molecule LibrariesArtificial intelligenceChemical librariesChemical spaceChemoinformaticsComputational chemistryDatabasesMolecular modelingStructure–property associations—SPA

Identifiers

PMID42223746
PMCPMC13226435

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.